Date and time: Tuesday, February 11, 2025 | 12:00 PM - 1:00 PM ET
2024 was an active year in Canadian patent law. Canadian courts issued several decisions on the merits regarding invalidity and/or infringement. They considered due care in the context of paying maintenance fees, regulatory issues related to patented medicines, and remedies available when a patent is infringed, among other patent related issues.
Our presenters Andrea Berenbaum, Ryan De Vries and Michael Sgro provide an annual summary of key developments in Canadian patent law. This webinar offers a valuable opportunity for legal professionals and others interested in Canadian patent law to gain an overview of developments in 2024. Speakers will highlight a significant statutory change and discuss notable points raised in the reported decisions.
Webinar replay:
Who should attend:
- in-house counsel
- patent agents and attorneys in private practice
- business owners and entrepreneurs
- technology transfer professionals
Speakers:
- Andrea Berenbaum: Andrea is a principal at Smart & Biggar. With a combined background in chemistry and visual biomedical communication design, Andrea’s practice focuses on chemical, pharmaceutical, and biotechnology patents, and includes the drafting and prosecution of such patents.
- Ryan De Vries: Ryan is a senior associate at Smart & Biggar. His practice includes preparing, filing, and successfully prosecuting patent and industrial design applications for mechanical, electrical, and computer technology, with a focus on mechanical subject matter.
- Michael Sgro: Michael is a senior associate at Smart & Biggar. With a background in chemistry, Michael’s experience covers the pharmaceutical and chemical patent sectors. He specializes in chemical compositions, small molecules (NCEs), semiconductors, polymers, catalysts and catalytic processes, and manufacturing processes and apparatuses.
Subscribe to be the first to receive updates on our webinars and other thought leadership content, sent straight to your inbox.